This work sought to create a comprehensive resource of the metabolic diversity of cancer. Part of the study involved pooling 544 adherent PRISM cell lines which were then grown under media conditions with varied amino acid concentration to understand the effect on cell viability.
PRISM will be accepting submissions for our next screen
January 27 – February 14, 2025!
This screen will be for DMSO-soluble small molecules only against the PRISM collection of 930 cancer cell lines.